News
- Author:
- Sara Freeman
Publish date: September 12, 2022
The research adds to existing evidence that “vitamin D levels can play an important and independent role in patients’ survival outcomes.”
News
- Author:
- Sara Freeman
Publish date: July 5, 2022
Development of new HBV drugs looks more complicated than initially expected, and it’s time to refine and refocus goals, according to one researcher...
News
- Author:
- Sara Freeman
Publish date: July 5, 2022
Statins could have multiple benefits in NAFLD, but there has been little insight into how they may be exerting such effects.
News
- Author:
- Sara Freeman
Publish date: July 5, 2022
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
News
- Author:
- Sara Freeman
Publish date: June 29, 2022
Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.
News
- Author:
- Sara Freeman
Publish date: June 27, 2022
The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.
News
- Author:
- Sara Freeman
Publish date: June 15, 2022
Developing depression after a diagnosis of rheumatoid arthritis substantially increased the risk for death over 10 years in a large Danish populati...
News
- Author:
- Sara Freeman
Publish date: June 14, 2022
The cohort study of German patients with and without the disease found no major sex-specific differences for erosion and bone marrow edema but did ...
News
- Author:
- Sara Freeman
Publish date: June 10, 2022
Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trial...
News
- Author:
- Sara Freeman
Publish date: June 7, 2022
Greater efficacy and fewer infusion reactions seen with methotrexate-pegloticase combination than pegloticase alone in the placebo-controlled MIRRO...
News
- Author:
- Sara Freeman
Publish date: June 5, 2022
Greater percentages of patients treated with one of two doses of the novel IL-17 blocker achieved an ACR50 response versus placebo.
News
- Author:
- Sara Freeman
Publish date: June 2, 2022
Avacopan and mepolizumab feature in new European recommendations for managing antineutrophil cytoplasmic antibody–associated vasculitis.
News
- Author:
- Sara Freeman
Publish date: May 16, 2022
Shielding status was the highest ranked of all the risk factors identified for early mortality from COVID-19.
News
- Author:
- Sara Freeman
Publish date: May 13, 2022
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
News
- Author:
- Sara Freeman
Publish date: May 10, 2022
Laboratory blood test results were similar despite moving from once every month to about once every 3 months or about once every 5 months during th...
